Urology Ultrasound Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032
Description
Urology Ultrasound Devices Market Summary
The global urology ultrasound devices market is expected to increase from USD 714.54 million in 2024 to USD 1,169.80 million by 2032, reflecting strong and sustained growth.
The global urology ultrasound devices market is growing at a CAGR of 6.41% during the forecast period from 2025 to 2032.
The global urology ultrasound devices market is driven by the rising prevalence of benign prostatic hyperplasia, increasing cases of prostate cancer, and increased instances of erectile dysfunction.
The leading companies operating in the urology ultrasound devices market include General Electric Company, ESAOTE SPA, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, BK Medical Holding Company, Inc., Hitachi Medical Systems, Laborie, DRAMIŃSKI S. A., Clarius Mobile Health Corp, AvantSonic Technology Co., Ltd, ProMed Solutions Inc, SIFSOF LLC, Shenzhen Ricso Technology Co. Ltd, Sonoscanner, Chengdu Healson Technology Co. Ltd, Healcerion Co., Ltd, Exact Imaging, ECHO-SON S.A., Xindray Medical International Co., Ltd, KOELIS, Interson Corporation, and others.
The North American urology ultrasound devices market is a dominant force globally, driven by increasing cases of kidney stones, the rising prevalence of urinary incontinence and bladder conditions, and the growing incidence of prostate cancer.
In the product type segment of the urology ultrasound devices market, the ultrasound systems category is estimated to account for the largest market share in 2024.
Factors Contributing to the Growth of the Urology Ultrasound Devices Market
The rising prevalence of urological disorders leading to a surge in the urology ultrasound devices market: The increasing occurrence of conditions such as benign prostatic hyperplasia (BPH), prostate cancer, kidney stones, urinary incontinence, and erectile dysfunction is significantly driving the demand for urology ultrasound devices. As the global population continues to age and lifestyle-related risk factors rise, these disorders are becoming more common, creating a greater need for accurate, non-invasive diagnostic tools to support early detection, monitoring, and treatment planning.
Growing adoption of point-of-care ultrasound leads to higher adoption of urology ultrasound devices: Point-of-care ultrasound (POCUS) is rapidly gaining traction in urology due to its ability to deliver immediate, bedside diagnostic insights. This approach not only enhances clinical efficiency but also improves patient convenience by reducing the need for multiple hospital visits and extensive diagnostic procedures. The portability and ease of use of modern ultrasound systems make them especially valuable in outpatient clinics, emergency care, and even home healthcare settings.
Advancements in imaging technology: Technological innovations are transforming urology ultrasound devices, making them more precise, versatile, and user-friendly. Features such as high-resolution 3D/4D imaging, AI-enabled diagnostic support, and improved software for image analysis are enhancing accuracy and reducing operator dependency. Additionally, the development of compact and handheld ultrasound systems is expanding access to advanced imaging, allowing clinicians to provide better patient care across diverse healthcare settings.
Urology Ultrasound Devices Market Report Segmentation
This urology ultrasound devices market report offers a comprehensive overview of the global urology ultrasound devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation of the Urology Ultrasound Devices Market by Modality (Non-Portable Device and Portable Device), Application (Diagnosis, Monitoring, and Treatment), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Diagnostic Centers), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing urology ultrasound devices market.
Urology ultrasound devices are specialized imaging systems used to visualize and assess the kidneys, bladder, prostate, and related urinary structures. They provide real-time, non-invasive imaging that aids in diagnosing conditions such as kidney stones, benign prostatic hyperplasia (BPH), prostate cancer, urinary incontinence, and erectile dysfunction. By offering detailed insights into organ size, structure, blood flow, and abnormalities, these devices support accurate diagnosis, guide minimally invasive procedures, and monitor treatment outcomes, making them essential tools in modern urological care.
The urology ultrasound devices market is experiencing robust growth, fueled by several key factors. The rising prevalence of urological disorders such as benign prostatic hyperplasia (BPH), prostate cancer, and erectile dysfunction is creating strong demand for reliable and efficient diagnostic tools. The growing adoption of point-of-care ultrasound is further accelerating market expansion, as it enables faster, more accessible, and patient-friendly diagnostics across hospitals, outpatient centers, and clinics. Additionally, continuous advancements in imaging technology, including AI integration, enhanced 3D/4D imaging, and improved portability, are significantly enhancing diagnostic accuracy and clinical decision-making. These trends, coupled with increasing awareness about early detection and expanding healthcare infrastructure, are expected to drive the sustained growth of the urology ultrasound devices market worldwide.
Get More Insights into the Report @Urology Ultrasound Devices Market
What are the latest Urology Ultrasound Devices Market Dynamics and Trends?
The urology ultrasound devices market is poised for significant growth, driven by the rising prevalence of urological disorders such as benign prostatic hyperplasia, prostate cancer, and erectile dysfunction. In addition, the growing adoption of point-of-care ultrasound is enhancing diagnostic efficiency and accessibility, particularly in outpatient and emergency care settings. Furthermore, advancements in imaging technology, including AI integration and high-resolution imaging, are improving diagnostic accuracy and treatment planning. Collectively, these factors are expected to strongly contribute to the expansion of the urology ultrasound devices market during the forecast period.
According to DelveInsight, in 2022, prostate cancer cases were significant worldwide, with Europe reporting 473,100 cases, Asia 386,500 cases, Latin America and the Caribbean (LAC) 226,000 cases, and Africa 103,100 cases. Urology ultrasound devices play a critical role in the management of prostate cancer by providing detailed imaging of the prostate gland, helping detect abnormalities, and guiding biopsies for accurate tissue sampling. These devices are also valuable in monitoring disease progression and evaluating treatment effectiveness, ensuring improved patient management across regions.
According to DelveInsight, the prevalence of benign prostatic hyperplasia (BPH) is estimated to affect 50–60% of men in their 60s and increases to nearly 80–90% in men over 70 years of age globally. Urology ultrasound devices are essential in the diagnosis and management of BPH, as they allow healthcare providers to visualize the prostate gland, assess its size and shape, and determine the degree of obstruction. This detailed imaging supports accurate diagnosis, monitoring of progression, and effective treatment planning, as well as guiding procedures that alleviate symptoms and improve quality of life in aging patients.
Furthermore, erectile dysfunction continues to be a widespread urological concern. According to DelveInsight, around 15% of men are affected annually, with more than 155 million men currently living with the condition worldwide, a figure projected to rise to 325 million by 2025. Urology ultrasound devices are crucial in diagnosing and managing erectile dysfunction by evaluating penile blood flow and tissue structure. They help identify underlying issues such as arterial blockages or venous leakage, guide therapeutic interventions, and monitor treatment outcomes, ultimately enabling personalized and effective patient care.
Hence, the interplay of all the above-mentioned factors is expected to drive the urology ultrasound devices market during the given forecast period.
Despite the increasing adoption of urology ultrasound devices, the market faces certain restraints that could limit its growth. Prolonged use of these devices can sometimes lead to skin irritation, rashes, or sores in patients, which raises concerns about comfort and safety during repeated examinations. Additionally, the availability of alternative imaging procedures such as MRI, CT, and PET scans presents a significant challenge, as these modalities are often preferred for their advanced imaging capabilities in complex cases. The presence of such alternatives may influence clinical decision-making and reduce reliance on ultrasound in certain scenarios. These factors collectively create barriers to widespread adoption and may slow down the overall growth trajectory of the market.
Urology Ultrasound Devices Market Segment Analysis
Urology Ultrasound Devices Market by Modality (Non-Portable Device and Portable Device), Application (Diagnosis, Monitoring, and Treatment), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Diagnostic Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
By Modality: Non-Portable Device Category Dominates the Market
The Non-portable device category represents the dominant segment in the urology ultrasound devices market, accounting for a substantial share of approximately 60% in 2024. This dominance is attributed to their superior image quality, advanced features, and versatility, making them the preferred choice for comprehensive diagnostics and complex procedures performed in hospitals and large diagnostic centers.
These systems are designed to provide exceptional resolution, deeper tissue penetration, and support for advanced imaging modalities such as 3D/4D and Doppler, making them indispensable for the accurate evaluation of complex urological conditions, including prostate cancer, kidney stones, and bladder disorders. Their widespread adoption in hospitals and specialty urology centers is further reinforced by their capacity to manage high patient volumes, deliver consistent diagnostic accuracy, and seamlessly integrate with hospital information systems and electronic medical records.
A strong example of this is the GE HealthCare LOGIQ F8, a non-portable ultrasound system extensively used in urology. It combines excellent image quality, advanced features, and intuitive workflows, enabling clinicians to effectively detect, assess, and monitor a wide range of urological conditions with precision and confidence. Systems like the LOGIQ F8 emphasize why non-portable devices continue to be the preferred choice in clinical environments, offering comprehensive, high-performance solutions tailored to the evolving demands of modern urology.
Therefore, driven by these factors, the non-portable segment is expected to maintain its dominance and play a crucial role in driving overall market growth during the forecast period.
By Application: Diagnosis Category Dominates the Market
In the urology ultrasound devices market, the diagnosis category held the largest market share, capturing nearly 61% of the global market in 2024. This is primarily due to the rising incidence of kidney-related disorders, such as kidney stones, benign prostatic hyperplasia (BPH), urinary incontinence, and various cancers, which require accurate imaging for diagnosis and management. Ultrasound is the preferred modality for renal assessment because it is non-invasive, radiation-free, cost-effective, and provides real-time imaging, making it ideal for monitoring kidney structure, detecting stones, assessing obstruction, and guiding minimally invasive interventions.
The continuous evolution of diagnostic technology is a major market driver. Modern devices offer enhanced features like AI integration for improved image analysis, 3D/4D imaging for better visualization, and miniaturization for point-of-care diagnostics. The development of portable and handheld ultrasound devices, for example, is making diagnostics more accessible and efficient, expanding the market's reach into outpatient clinics and remote settings.
The combination of clinical necessity, ease of use, and technological advancements in renal-focused ultrasound devices positions renal treatment as the leading segment in the urology ultrasound market.
While the treatment segment, which includes surgical and therapeutic devices, also represents a significant portion of the market, the sheer volume and frequency of diagnostic and monitoring procedures required for a wide range of urological conditions ensure that this category maintains its leading position. The ongoing need for routine check-ups, follow-up monitoring of chronic conditions, and initial disease screening establishes a high and recurring demand for these devices.
By End-User: Hospitals Dominate the Market
The hospital category held the largest market share, capturing nearly 43% of the global market in 2024. The Hospitals & Clinics segment dominates the urology ultrasound devices market primarily due to their role as the primary point of care for diagnosis and treatment of urological disorders. Hospitals and clinics have the necessary infrastructure, skilled personnel, and access to advanced imaging systems, allowing them to perform a wide range of urological assessments, including evaluation of kidney stones, prostate abnormalities, and bladder conditions.
Additionally, these facilities handle a high patient volume, which increases the demand for reliable and efficient ultrasound devices. The preference for hospitals and clinics is also driven by the need for comprehensive diagnostic capabilities, integration with other imaging and electronic health record systems, and the ability to support both outpatient and inpatient procedures. Overall, the combination of infrastructure, expertise, and patient throughput makes hospitals and clinics the largest end-users of urology ultrasound devices.
Urology Ultrasound Devices Market Regional Analysis
North America Urology Ultrasound Devices Market Trends
North America, led by the United States, dominates the global urology ultrasound devices market, accounting for approximately 41% of the total market share in 2024. The North American urology ultrasound devices market is witnessing steady growth, driven by multiple factors, including the rising incidence of kidney stones, increasing prevalence of urinary incontinence and other bladder conditions, growing cases of prostate cancer, and ongoing product development activities supported by regulatory bodies.
In the U.S., nearly 1 in 11 individuals experience kidney stones at some point in their lives, with incidence rates continuing to rise. Additionally, over 33 million people in the U.S. are affected by some form of urinary incontinence or bladder condition. Urology ultrasound devices play a critical role in diagnosing and managing these conditions by accurately assessing kidney stone size and location, evaluating bladder function and structure, and guiding treatment planning.
Prostate cancer further contributes to market growth, with the U.S. accounting for 230,125 cases and Canada 25,560 cases. Projections indicate that by 2050, prostate cancer cases in North America could reach 346,000. Ultrasound devices are essential for prostate cancer management, helping detect and evaluate abnormalities, determine tumor size and location, and support accurate staging and treatment planning.
Regulatory-driven product development is also bolstering the market. For instance, Clarius Mobile Health received FDA 510(k) clearance for its Clarius Bladder AI, an AI-enabled tool that automatically measures bladder volume, while in May 2024, the FDA cleared the Contouring Assistant, a machine-learning tool for prostate segmentation that works with the TULSA-PRO system to aid in precise ablation planning during Transurethral Ultrasound Ablation procedures.
Thus, the combination of rising disease prevalence, technological advancements, and supportive regulatory initiatives creates a favorable growth environment for the urology ultrasound devices market in North America over the forecast period.
Europe Urology Ultrasound Devices Market Trends
The Europe urology ultrasound devices market is witnessing notable trends driven by both technological advancements and evolving healthcare needs. One of the key trends is the growing adoption of portable and point-of-care ultrasound systems, which allow urologists to perform quick, accurate assessments in clinics and outpatient settings, improving patient convenience and workflow efficiency. AI-enabled imaging and advanced software solutions are increasingly being integrated into urology ultrasound devices, enhancing diagnostic accuracy, reducing operator dependency, and supporting better treatment planning. There is also a rising focus on minimally invasive procedures, driving demand for high-resolution imaging devices that can support guided interventions. A
dditionally, healthcare providers in Europe are increasingly investing in digital solutions that allow for better data management, telemedicine integration, and remote consultations. The market is further influenced by increasing awareness of urological disorders, an aging population, and rising prevalence of conditions such as kidney stones, prostate disorders, and urinary tract diseases, which collectively stimulate demand for advanced ultrasound diagnostics. Thus, the European market reflects a shift toward smarter, more efficient, and patient-centric urology imaging solutions.
Asia-Pacific Urology Ultrasound Devices Market Trends
The Asia-Pacific urology ultrasound devices market is witnessing rapid expansion, reflecting a robust CAGR of 7.25% during the forecast period from 2025 to 2032. The Asia-Pacific urology ultrasound devices market is witnessing significant growth, driven by a combination of rising healthcare awareness, increasing prevalence of urological disorders, and rapid advancements in medical imaging technologies. The adoption of portable and point-of-care ultrasound devices is becoming increasingly popular in the region, particularly in emerging economies where access to advanced hospital infrastructure may be limited. Integration of AI and machine learning in urology imaging solutions is enhancing diagnostic accuracy and efficiency, further boosting demand.
Additionally, government initiatives to improve healthcare infrastructure, along with growing investments in hospital modernization and outpatient facilities, are creating favorable market conditions. The increasing focus on early detection and minimally invasive procedures is also encouraging the uptake of advanced ultrasound devices among urologists. Overall, the Asia-Pacific market is experiencing a robust expansion, driven by technological innovation, rising patient demand, and improved accessibility to healthcare services.
Who are the major players in the Urology Ultrasound Devices Market?
The following are the leading companies in the Urology Ultrasound Devices market. These companies collectively hold the largest market share and dictate industry trends.
General Electric Company
ESAOTE SPA
Shenzhen Mindray Bio-Medical Electronics Co., Ltd
BK Medical Holding Company, Inc.
Hitachi Medical Systems
Laborie
DRAMINSKI S. A.
Clarius Mobile Health Corp
AvantSonic Technology Co., Ltd
ProMed Solutions Inc
SIFSOF LLC
Shenzhen Ricso Technology Co., Ltd
Sonoscanner
Chengdu Healson Technology Co., Ltd
Healcerion Co., Ltd
Exact Imaging
ECHO-SON S.A.
Xindray Medical International Co., Ltd
KOELIS
Interson Corporation
How is the competitive landscape shaping the Urology Ultrasound Devices Market?
The competitive landscape of the urology ultrasound devices market is highly concentrated, with a few multinational corporations holding a dominant market share. Major players such as GE HealthCare, Siemens Healthineers, Koninklijke Philips N.V., and Canon Medical Systems command a significant portion of the market, particularly in the high-end, cart-based segment. Their dominance is a result of extensive R&D capabilities, strong brand recognition, and broad product portfolios that cater to a wide range of clinical needs. However, the market is also becoming more dynamic with the emergence of smaller, innovative companies like Mindray Medical and specialized firms in the portable and handheld ultrasound space (e.g., FUJIFILM SonoSite). These smaller players are shaping the market by focusing on affordability, portability, and user-friendly designs that are ideal for point-of-care applications. Competition is increasingly shifting from a pure focus on hardware to technological advancements like AI-powered software, fusion imaging, and enhanced connectivity, which improve diagnostic accuracy and clinical workflow. This blend of established giants and agile innovators is creating a competitive environment where both market leaders and niche players are vying for growth by addressing specific segments of the evolving urology market.
Urology Ultrasound Devices Market Segmentation
Urology Ultrasound Devices Modality Exposure
Canada Urology Ultrasound Devices Market
Mexico Urology Ultrasound Devices Market
Germany Urology Ultrasound Devices Market
France Urology Ultrasound Devices Market
Italy Urology Ultrasound Devices Market
Spain Urology Ultrasound Devices Market
Rest of Europe Urology Ultrasound Devices Market
Japan Urology Ultrasound Devices Market
India Urology Ultrasound Devices Market
Australia Urology Ultrasound Devices Market
South Korea Urology Ultrasound Devices Market
Rest of Asia-Pacific Urology Ultrasound Devices Market
Middle East Urology Ultrasound Devices Market
Africa Urology Ultrasound Devices Market
Impact Analysis
AI-Powered Innovations and Applications:
AI-powered innovations are transforming the urology ultrasound devices market by enhancing diagnostic accuracy, workflow efficiency, and clinical decision-making. Advanced algorithms can now assist in detecting abnormalities such as kidney stones, prostate lesions, and bladder dysfunctions with greater precision, reducing the reliance on operator expertise and minimizing human error. Integration of AI into ultrasound systems also enables real-time image analysis, automated measurements, and predictive analytics, allowing for faster and more informed treatment planning. Additionally, AI-driven platforms support personalized patient care by tracking disease progression and suggesting optimized intervention strategies. These technological advancements not only improve clinical outcomes but also streamline operations in hospitals and clinics, making urology ultrasound diagnostics faster, more reliable, and increasingly accessible.
U.S. Tariff Impact Analysis on the Urology Ultrasound Devices Market:
The U.S. tariffs have had a notable impact on the urology ultrasound devices market, creating both operational and financial challenges for manufacturers. Companies relying on global supply chains have faced increased production costs due to higher tariffs on essential components, which have, in turn, led to elevated prices for ultrasound equipment. These cost pressures have prompted manufacturers to explore strategies such as diversifying suppliers, adjusting production locations, or optimizing their product portfolios to mitigate the financial burden. At the same time, healthcare providers have become more cautious in their purchasing decisions, often delaying investments or opting for refurbished equipment to manage expenses. The tariffs have introduced a layer of uncertainty in the market, influencing pricing strategies, procurement patterns, and the adoption of newer technologies, while pushing manufacturers to adapt strategically to maintain competitiveness.
How This Analysis Helps Clients
Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.
Key takeaways from the Urology Ultrasound Devices market report study
Market size analysis for the current urology ultrasound devices market size (2024), and market forecast for 8 years (2025 to 2032)
Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
Key companies dominating the urology ultrasound devices market.
Various opportunities available for the other competitors in the urology ultrasound devices market space.
What are the top-performing segments in 2024How these segments will perform in 2032?
Which are the top-performing regions and countries in the current urology ultrasound devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for the urology ultrasound devices market growth in the future?
Frequently Asked Questions for the Urology Ultrasound Devices Market
1. What is the growth rate of the urology ultrasound devices market?
The urology ultrasound devices market is estimated to grow at a CAGR of 6.41% during the forecast period from 2025 to 2032.
2. What is the market for urology ultrasound devices?
The urology ultrasound devices market was valued at USD 714.54 million in 2024, and is expected to reach USD 1,169.80 million by 2032.
3. Which region has the highest share in the urology ultrasound devices market?
The North American urology ultrasound devices market is a dominant force globally, driven by increasing cases of kidney stones, the rising prevalence of urinary incontinence and bladder conditions, and the growing incidence of prostate cancer.
4. What are the drivers for the urology ultrasound devices market?
The global urology ultrasound devices market is driven by the rising prevalence of benign prostatic hyperplasia, increasing cases of prostate cancer, and increased instances of erectile dysfunction.
5. Who are the key players operating in the urology ultrasound devices market?
Some of the key market players operating in the urology ultrasound devices market are General Electric Company, ESAOTE SPA, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, BK Medical Holding Company, Inc., Hitachi Medical Systems, Laborie, DRAMINSKI S.A., Clarius Mobile Health Corp, AvantSonic Technology Co., Ltd, ProMed Solutions Inc., SIFSOF LLC, Shenzhen Ricso Technology Co., Ltd, Sonoscanner, Chengdu Healson Technology Co., Ltd, Healcerion Co., Ltd, Exact Imaging, ECHO-SON S.A., Xindray Medical International Co., Ltd, KOELIS, Interson Corporation, and Others.
The global urology ultrasound devices market is expected to increase from USD 714.54 million in 2024 to USD 1,169.80 million by 2032, reflecting strong and sustained growth.
The global urology ultrasound devices market is growing at a CAGR of 6.41% during the forecast period from 2025 to 2032.
The global urology ultrasound devices market is driven by the rising prevalence of benign prostatic hyperplasia, increasing cases of prostate cancer, and increased instances of erectile dysfunction.
The leading companies operating in the urology ultrasound devices market include General Electric Company, ESAOTE SPA, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, BK Medical Holding Company, Inc., Hitachi Medical Systems, Laborie, DRAMIŃSKI S. A., Clarius Mobile Health Corp, AvantSonic Technology Co., Ltd, ProMed Solutions Inc, SIFSOF LLC, Shenzhen Ricso Technology Co. Ltd, Sonoscanner, Chengdu Healson Technology Co. Ltd, Healcerion Co., Ltd, Exact Imaging, ECHO-SON S.A., Xindray Medical International Co., Ltd, KOELIS, Interson Corporation, and others.
The North American urology ultrasound devices market is a dominant force globally, driven by increasing cases of kidney stones, the rising prevalence of urinary incontinence and bladder conditions, and the growing incidence of prostate cancer.
In the product type segment of the urology ultrasound devices market, the ultrasound systems category is estimated to account for the largest market share in 2024.
Factors Contributing to the Growth of the Urology Ultrasound Devices Market
The rising prevalence of urological disorders leading to a surge in the urology ultrasound devices market: The increasing occurrence of conditions such as benign prostatic hyperplasia (BPH), prostate cancer, kidney stones, urinary incontinence, and erectile dysfunction is significantly driving the demand for urology ultrasound devices. As the global population continues to age and lifestyle-related risk factors rise, these disorders are becoming more common, creating a greater need for accurate, non-invasive diagnostic tools to support early detection, monitoring, and treatment planning.
Growing adoption of point-of-care ultrasound leads to higher adoption of urology ultrasound devices: Point-of-care ultrasound (POCUS) is rapidly gaining traction in urology due to its ability to deliver immediate, bedside diagnostic insights. This approach not only enhances clinical efficiency but also improves patient convenience by reducing the need for multiple hospital visits and extensive diagnostic procedures. The portability and ease of use of modern ultrasound systems make them especially valuable in outpatient clinics, emergency care, and even home healthcare settings.
Advancements in imaging technology: Technological innovations are transforming urology ultrasound devices, making them more precise, versatile, and user-friendly. Features such as high-resolution 3D/4D imaging, AI-enabled diagnostic support, and improved software for image analysis are enhancing accuracy and reducing operator dependency. Additionally, the development of compact and handheld ultrasound systems is expanding access to advanced imaging, allowing clinicians to provide better patient care across diverse healthcare settings.
Urology Ultrasound Devices Market Report Segmentation
This urology ultrasound devices market report offers a comprehensive overview of the global urology ultrasound devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation of the Urology Ultrasound Devices Market by Modality (Non-Portable Device and Portable Device), Application (Diagnosis, Monitoring, and Treatment), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Diagnostic Centers), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing urology ultrasound devices market.
Urology ultrasound devices are specialized imaging systems used to visualize and assess the kidneys, bladder, prostate, and related urinary structures. They provide real-time, non-invasive imaging that aids in diagnosing conditions such as kidney stones, benign prostatic hyperplasia (BPH), prostate cancer, urinary incontinence, and erectile dysfunction. By offering detailed insights into organ size, structure, blood flow, and abnormalities, these devices support accurate diagnosis, guide minimally invasive procedures, and monitor treatment outcomes, making them essential tools in modern urological care.
The urology ultrasound devices market is experiencing robust growth, fueled by several key factors. The rising prevalence of urological disorders such as benign prostatic hyperplasia (BPH), prostate cancer, and erectile dysfunction is creating strong demand for reliable and efficient diagnostic tools. The growing adoption of point-of-care ultrasound is further accelerating market expansion, as it enables faster, more accessible, and patient-friendly diagnostics across hospitals, outpatient centers, and clinics. Additionally, continuous advancements in imaging technology, including AI integration, enhanced 3D/4D imaging, and improved portability, are significantly enhancing diagnostic accuracy and clinical decision-making. These trends, coupled with increasing awareness about early detection and expanding healthcare infrastructure, are expected to drive the sustained growth of the urology ultrasound devices market worldwide.
Get More Insights into the Report @Urology Ultrasound Devices Market
What are the latest Urology Ultrasound Devices Market Dynamics and Trends?
The urology ultrasound devices market is poised for significant growth, driven by the rising prevalence of urological disorders such as benign prostatic hyperplasia, prostate cancer, and erectile dysfunction. In addition, the growing adoption of point-of-care ultrasound is enhancing diagnostic efficiency and accessibility, particularly in outpatient and emergency care settings. Furthermore, advancements in imaging technology, including AI integration and high-resolution imaging, are improving diagnostic accuracy and treatment planning. Collectively, these factors are expected to strongly contribute to the expansion of the urology ultrasound devices market during the forecast period.
According to DelveInsight, in 2022, prostate cancer cases were significant worldwide, with Europe reporting 473,100 cases, Asia 386,500 cases, Latin America and the Caribbean (LAC) 226,000 cases, and Africa 103,100 cases. Urology ultrasound devices play a critical role in the management of prostate cancer by providing detailed imaging of the prostate gland, helping detect abnormalities, and guiding biopsies for accurate tissue sampling. These devices are also valuable in monitoring disease progression and evaluating treatment effectiveness, ensuring improved patient management across regions.
According to DelveInsight, the prevalence of benign prostatic hyperplasia (BPH) is estimated to affect 50–60% of men in their 60s and increases to nearly 80–90% in men over 70 years of age globally. Urology ultrasound devices are essential in the diagnosis and management of BPH, as they allow healthcare providers to visualize the prostate gland, assess its size and shape, and determine the degree of obstruction. This detailed imaging supports accurate diagnosis, monitoring of progression, and effective treatment planning, as well as guiding procedures that alleviate symptoms and improve quality of life in aging patients.
Furthermore, erectile dysfunction continues to be a widespread urological concern. According to DelveInsight, around 15% of men are affected annually, with more than 155 million men currently living with the condition worldwide, a figure projected to rise to 325 million by 2025. Urology ultrasound devices are crucial in diagnosing and managing erectile dysfunction by evaluating penile blood flow and tissue structure. They help identify underlying issues such as arterial blockages or venous leakage, guide therapeutic interventions, and monitor treatment outcomes, ultimately enabling personalized and effective patient care.
Hence, the interplay of all the above-mentioned factors is expected to drive the urology ultrasound devices market during the given forecast period.
Despite the increasing adoption of urology ultrasound devices, the market faces certain restraints that could limit its growth. Prolonged use of these devices can sometimes lead to skin irritation, rashes, or sores in patients, which raises concerns about comfort and safety during repeated examinations. Additionally, the availability of alternative imaging procedures such as MRI, CT, and PET scans presents a significant challenge, as these modalities are often preferred for their advanced imaging capabilities in complex cases. The presence of such alternatives may influence clinical decision-making and reduce reliance on ultrasound in certain scenarios. These factors collectively create barriers to widespread adoption and may slow down the overall growth trajectory of the market.
Urology Ultrasound Devices Market Segment Analysis
Urology Ultrasound Devices Market by Modality (Non-Portable Device and Portable Device), Application (Diagnosis, Monitoring, and Treatment), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Diagnostic Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
By Modality: Non-Portable Device Category Dominates the Market
The Non-portable device category represents the dominant segment in the urology ultrasound devices market, accounting for a substantial share of approximately 60% in 2024. This dominance is attributed to their superior image quality, advanced features, and versatility, making them the preferred choice for comprehensive diagnostics and complex procedures performed in hospitals and large diagnostic centers.
These systems are designed to provide exceptional resolution, deeper tissue penetration, and support for advanced imaging modalities such as 3D/4D and Doppler, making them indispensable for the accurate evaluation of complex urological conditions, including prostate cancer, kidney stones, and bladder disorders. Their widespread adoption in hospitals and specialty urology centers is further reinforced by their capacity to manage high patient volumes, deliver consistent diagnostic accuracy, and seamlessly integrate with hospital information systems and electronic medical records.
A strong example of this is the GE HealthCare LOGIQ F8, a non-portable ultrasound system extensively used in urology. It combines excellent image quality, advanced features, and intuitive workflows, enabling clinicians to effectively detect, assess, and monitor a wide range of urological conditions with precision and confidence. Systems like the LOGIQ F8 emphasize why non-portable devices continue to be the preferred choice in clinical environments, offering comprehensive, high-performance solutions tailored to the evolving demands of modern urology.
Therefore, driven by these factors, the non-portable segment is expected to maintain its dominance and play a crucial role in driving overall market growth during the forecast period.
By Application: Diagnosis Category Dominates the Market
In the urology ultrasound devices market, the diagnosis category held the largest market share, capturing nearly 61% of the global market in 2024. This is primarily due to the rising incidence of kidney-related disorders, such as kidney stones, benign prostatic hyperplasia (BPH), urinary incontinence, and various cancers, which require accurate imaging for diagnosis and management. Ultrasound is the preferred modality for renal assessment because it is non-invasive, radiation-free, cost-effective, and provides real-time imaging, making it ideal for monitoring kidney structure, detecting stones, assessing obstruction, and guiding minimally invasive interventions.
The continuous evolution of diagnostic technology is a major market driver. Modern devices offer enhanced features like AI integration for improved image analysis, 3D/4D imaging for better visualization, and miniaturization for point-of-care diagnostics. The development of portable and handheld ultrasound devices, for example, is making diagnostics more accessible and efficient, expanding the market's reach into outpatient clinics and remote settings.
The combination of clinical necessity, ease of use, and technological advancements in renal-focused ultrasound devices positions renal treatment as the leading segment in the urology ultrasound market.
While the treatment segment, which includes surgical and therapeutic devices, also represents a significant portion of the market, the sheer volume and frequency of diagnostic and monitoring procedures required for a wide range of urological conditions ensure that this category maintains its leading position. The ongoing need for routine check-ups, follow-up monitoring of chronic conditions, and initial disease screening establishes a high and recurring demand for these devices.
By End-User: Hospitals Dominate the Market
The hospital category held the largest market share, capturing nearly 43% of the global market in 2024. The Hospitals & Clinics segment dominates the urology ultrasound devices market primarily due to their role as the primary point of care for diagnosis and treatment of urological disorders. Hospitals and clinics have the necessary infrastructure, skilled personnel, and access to advanced imaging systems, allowing them to perform a wide range of urological assessments, including evaluation of kidney stones, prostate abnormalities, and bladder conditions.
Additionally, these facilities handle a high patient volume, which increases the demand for reliable and efficient ultrasound devices. The preference for hospitals and clinics is also driven by the need for comprehensive diagnostic capabilities, integration with other imaging and electronic health record systems, and the ability to support both outpatient and inpatient procedures. Overall, the combination of infrastructure, expertise, and patient throughput makes hospitals and clinics the largest end-users of urology ultrasound devices.
Urology Ultrasound Devices Market Regional Analysis
North America Urology Ultrasound Devices Market Trends
North America, led by the United States, dominates the global urology ultrasound devices market, accounting for approximately 41% of the total market share in 2024. The North American urology ultrasound devices market is witnessing steady growth, driven by multiple factors, including the rising incidence of kidney stones, increasing prevalence of urinary incontinence and other bladder conditions, growing cases of prostate cancer, and ongoing product development activities supported by regulatory bodies.
In the U.S., nearly 1 in 11 individuals experience kidney stones at some point in their lives, with incidence rates continuing to rise. Additionally, over 33 million people in the U.S. are affected by some form of urinary incontinence or bladder condition. Urology ultrasound devices play a critical role in diagnosing and managing these conditions by accurately assessing kidney stone size and location, evaluating bladder function and structure, and guiding treatment planning.
Prostate cancer further contributes to market growth, with the U.S. accounting for 230,125 cases and Canada 25,560 cases. Projections indicate that by 2050, prostate cancer cases in North America could reach 346,000. Ultrasound devices are essential for prostate cancer management, helping detect and evaluate abnormalities, determine tumor size and location, and support accurate staging and treatment planning.
Regulatory-driven product development is also bolstering the market. For instance, Clarius Mobile Health received FDA 510(k) clearance for its Clarius Bladder AI, an AI-enabled tool that automatically measures bladder volume, while in May 2024, the FDA cleared the Contouring Assistant, a machine-learning tool for prostate segmentation that works with the TULSA-PRO system to aid in precise ablation planning during Transurethral Ultrasound Ablation procedures.
Thus, the combination of rising disease prevalence, technological advancements, and supportive regulatory initiatives creates a favorable growth environment for the urology ultrasound devices market in North America over the forecast period.
Europe Urology Ultrasound Devices Market Trends
The Europe urology ultrasound devices market is witnessing notable trends driven by both technological advancements and evolving healthcare needs. One of the key trends is the growing adoption of portable and point-of-care ultrasound systems, which allow urologists to perform quick, accurate assessments in clinics and outpatient settings, improving patient convenience and workflow efficiency. AI-enabled imaging and advanced software solutions are increasingly being integrated into urology ultrasound devices, enhancing diagnostic accuracy, reducing operator dependency, and supporting better treatment planning. There is also a rising focus on minimally invasive procedures, driving demand for high-resolution imaging devices that can support guided interventions. A
dditionally, healthcare providers in Europe are increasingly investing in digital solutions that allow for better data management, telemedicine integration, and remote consultations. The market is further influenced by increasing awareness of urological disorders, an aging population, and rising prevalence of conditions such as kidney stones, prostate disorders, and urinary tract diseases, which collectively stimulate demand for advanced ultrasound diagnostics. Thus, the European market reflects a shift toward smarter, more efficient, and patient-centric urology imaging solutions.
Asia-Pacific Urology Ultrasound Devices Market Trends
The Asia-Pacific urology ultrasound devices market is witnessing rapid expansion, reflecting a robust CAGR of 7.25% during the forecast period from 2025 to 2032. The Asia-Pacific urology ultrasound devices market is witnessing significant growth, driven by a combination of rising healthcare awareness, increasing prevalence of urological disorders, and rapid advancements in medical imaging technologies. The adoption of portable and point-of-care ultrasound devices is becoming increasingly popular in the region, particularly in emerging economies where access to advanced hospital infrastructure may be limited. Integration of AI and machine learning in urology imaging solutions is enhancing diagnostic accuracy and efficiency, further boosting demand.
Additionally, government initiatives to improve healthcare infrastructure, along with growing investments in hospital modernization and outpatient facilities, are creating favorable market conditions. The increasing focus on early detection and minimally invasive procedures is also encouraging the uptake of advanced ultrasound devices among urologists. Overall, the Asia-Pacific market is experiencing a robust expansion, driven by technological innovation, rising patient demand, and improved accessibility to healthcare services.
Who are the major players in the Urology Ultrasound Devices Market?
The following are the leading companies in the Urology Ultrasound Devices market. These companies collectively hold the largest market share and dictate industry trends.
General Electric Company
ESAOTE SPA
Shenzhen Mindray Bio-Medical Electronics Co., Ltd
BK Medical Holding Company, Inc.
Hitachi Medical Systems
Laborie
DRAMINSKI S. A.
Clarius Mobile Health Corp
AvantSonic Technology Co., Ltd
ProMed Solutions Inc
SIFSOF LLC
Shenzhen Ricso Technology Co., Ltd
Sonoscanner
Chengdu Healson Technology Co., Ltd
Healcerion Co., Ltd
Exact Imaging
ECHO-SON S.A.
Xindray Medical International Co., Ltd
KOELIS
Interson Corporation
How is the competitive landscape shaping the Urology Ultrasound Devices Market?
The competitive landscape of the urology ultrasound devices market is highly concentrated, with a few multinational corporations holding a dominant market share. Major players such as GE HealthCare, Siemens Healthineers, Koninklijke Philips N.V., and Canon Medical Systems command a significant portion of the market, particularly in the high-end, cart-based segment. Their dominance is a result of extensive R&D capabilities, strong brand recognition, and broad product portfolios that cater to a wide range of clinical needs. However, the market is also becoming more dynamic with the emergence of smaller, innovative companies like Mindray Medical and specialized firms in the portable and handheld ultrasound space (e.g., FUJIFILM SonoSite). These smaller players are shaping the market by focusing on affordability, portability, and user-friendly designs that are ideal for point-of-care applications. Competition is increasingly shifting from a pure focus on hardware to technological advancements like AI-powered software, fusion imaging, and enhanced connectivity, which improve diagnostic accuracy and clinical workflow. This blend of established giants and agile innovators is creating a competitive environment where both market leaders and niche players are vying for growth by addressing specific segments of the evolving urology market.
Urology Ultrasound Devices Market Segmentation
Urology Ultrasound Devices Modality Exposure
- Non-Portable Device
- Portable Device
- Diagnosis
- Monitoring
- Treatment
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
- North America Urology Ultrasound Devices Market
Canada Urology Ultrasound Devices Market
Mexico Urology Ultrasound Devices Market
- Europe Urology Ultrasound Devices Market
Germany Urology Ultrasound Devices Market
France Urology Ultrasound Devices Market
Italy Urology Ultrasound Devices Market
Spain Urology Ultrasound Devices Market
Rest of Europe Urology Ultrasound Devices Market
- Asia-Pacific Urology Ultrasound Devices Market
Japan Urology Ultrasound Devices Market
India Urology Ultrasound Devices Market
Australia Urology Ultrasound Devices Market
South Korea Urology Ultrasound Devices Market
Rest of Asia-Pacific Urology Ultrasound Devices Market
- Rest of the World Urology Ultrasound Devices Market
Middle East Urology Ultrasound Devices Market
Africa Urology Ultrasound Devices Market
Impact Analysis
AI-Powered Innovations and Applications:
AI-powered innovations are transforming the urology ultrasound devices market by enhancing diagnostic accuracy, workflow efficiency, and clinical decision-making. Advanced algorithms can now assist in detecting abnormalities such as kidney stones, prostate lesions, and bladder dysfunctions with greater precision, reducing the reliance on operator expertise and minimizing human error. Integration of AI into ultrasound systems also enables real-time image analysis, automated measurements, and predictive analytics, allowing for faster and more informed treatment planning. Additionally, AI-driven platforms support personalized patient care by tracking disease progression and suggesting optimized intervention strategies. These technological advancements not only improve clinical outcomes but also streamline operations in hospitals and clinics, making urology ultrasound diagnostics faster, more reliable, and increasingly accessible.
U.S. Tariff Impact Analysis on the Urology Ultrasound Devices Market:
The U.S. tariffs have had a notable impact on the urology ultrasound devices market, creating both operational and financial challenges for manufacturers. Companies relying on global supply chains have faced increased production costs due to higher tariffs on essential components, which have, in turn, led to elevated prices for ultrasound equipment. These cost pressures have prompted manufacturers to explore strategies such as diversifying suppliers, adjusting production locations, or optimizing their product portfolios to mitigate the financial burden. At the same time, healthcare providers have become more cautious in their purchasing decisions, often delaying investments or opting for refurbished equipment to manage expenses. The tariffs have introduced a layer of uncertainty in the market, influencing pricing strategies, procurement patterns, and the adoption of newer technologies, while pushing manufacturers to adapt strategically to maintain competitiveness.
How This Analysis Helps Clients
Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.
Key takeaways from the Urology Ultrasound Devices market report study
Market size analysis for the current urology ultrasound devices market size (2024), and market forecast for 8 years (2025 to 2032)
Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
Key companies dominating the urology ultrasound devices market.
Various opportunities available for the other competitors in the urology ultrasound devices market space.
What are the top-performing segments in 2024How these segments will perform in 2032?
Which are the top-performing regions and countries in the current urology ultrasound devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for the urology ultrasound devices market growth in the future?
Frequently Asked Questions for the Urology Ultrasound Devices Market
1. What is the growth rate of the urology ultrasound devices market?
The urology ultrasound devices market is estimated to grow at a CAGR of 6.41% during the forecast period from 2025 to 2032.
2. What is the market for urology ultrasound devices?
The urology ultrasound devices market was valued at USD 714.54 million in 2024, and is expected to reach USD 1,169.80 million by 2032.
3. Which region has the highest share in the urology ultrasound devices market?
The North American urology ultrasound devices market is a dominant force globally, driven by increasing cases of kidney stones, the rising prevalence of urinary incontinence and bladder conditions, and the growing incidence of prostate cancer.
4. What are the drivers for the urology ultrasound devices market?
The global urology ultrasound devices market is driven by the rising prevalence of benign prostatic hyperplasia, increasing cases of prostate cancer, and increased instances of erectile dysfunction.
5. Who are the key players operating in the urology ultrasound devices market?
Some of the key market players operating in the urology ultrasound devices market are General Electric Company, ESAOTE SPA, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, BK Medical Holding Company, Inc., Hitachi Medical Systems, Laborie, DRAMINSKI S.A., Clarius Mobile Health Corp, AvantSonic Technology Co., Ltd, ProMed Solutions Inc., SIFSOF LLC, Shenzhen Ricso Technology Co., Ltd, Sonoscanner, Chengdu Healson Technology Co., Ltd, Healcerion Co., Ltd, Exact Imaging, ECHO-SON S.A., Xindray Medical International Co., Ltd, KOELIS, Interson Corporation, and Others.
Table of Contents
150 Pages
- 1. Urology Ultrasound Devices Market Report Introduction
- 1.1 Scope of the Study
- 1.2 Market Segmentation
- 1.3 Market Assumption
- 2. Urology Ultrasound Devices Market Executive Summary
- 2.1 Market at Glance
- 3. Urology Ultrasound Devices Market Key Factors Analysis
- 3.1 Urology Ultrasound Devices Market Drivers
- 3.1.1 Rising prevalence of urological disorders
- 3.1.2 Growing adoption of point-of-care ultrasound
- 3.1.3 Advancements in imaging technology
- 3.2 Urology Ultrasound Devices Market Restraints and Challenges
- 3.2.1 Skin irritation, rashes, or sores associated with prolonged contact
- 3.2.2 Availability of alternative imaging procedure
- 3.3 Urology Ultrasound Devices Market Opportunity
- 3.3.1 Incorporating artificial intelligence and machine learning to enhance image interpretation
- 3.3.2 Integrating urology ultrasound with other imaging modalities
- 4. Impact Analysis
- 4.1 AI-Powered Innovations and Applications
- 4.2 U.S. Tariff Impact Analysis
- 5. Regulatory Analysis
- 5.1 The United States
- 5.2 Europe
- 5.3 Japan
- 5.4 China
- 6. Urology Ultrasound Devices Market Porter’s Five Forces Analysis
- 6.1 Bargaining Power of Suppliers
- 6.2 Bargaining Power of Consumers
- 6.3 Threat of New Entrants
- 6.4 Threat of Substitutes
- 6.5 Competitive Rivalry
- 7. Urology Ultrasound Devices Market Assessment
- 7.1 By Modality
- 7.1.1 Non-Portable Device
- 7.1.2 Portable Device
- 7.2 By Application
- 7.2.1 Diagnosis
- 7.2.2 Monitoring
- 7.2.3 Treatment
- 7.3 By End-User
- 7.3.1 Hospitals & Clinics
- 7.3.2 Ambulatory Surgical Centers
- 7.3.3 Diagnostic Centers
- 7.4 By Geography
- 7.4.1 North America
- 7.4.1.1 United States Urology Ultrasound Devices Market Size in USD million (2022-2032)
- 7.4.1.2 Canada Urology Ultrasound Devices Market Size in USD million (2022-2032)
- 7.4.1.3 Mexico Urology Ultrasound Devices Market Size in USD million (2022-2032)
- 7.4.2 Europe
- 7.4.2.1 France Urology Ultrasound Devices Market Size in USD million (2022-2032)
- 7.4.2.2 Germany Urology Ultrasound Devices Market Size in USD million (2022-2032)
- 7.4.2.3 United Kingdom Urology Ultrasound Devices Market Size in USD million (2022-2032)
- 7.4.2.4 Italy Urology Ultrasound Devices Market Size in USD million (2022-2032)
- 7.4.2.5 Spain Urology Ultrasound Devices Market Size in USD million (2022-2032)
- 7.4.2.6 Rest of Europe Urology Ultrasound Devices Market Size in USD million (2022-2032)
- 7.4.3 Asia-Pacific
- 7.4.3.1 China Urology Ultrasound Devices Market Size in USD million (2022-2032)
- 7.4.3.2 Japan Urology Ultrasound Devices Market Size in USD million (2022-2032)
- 7.4.3.3 India Urology Ultrasound Devices Market Size in USD million (2022-2032)
- 7.4.3.4 Australia Urology Ultrasound Devices Market Size in USD million (2022-2032)
- 7.4.3.5 South Korea Urology Ultrasound Devices Market Size in USD million (2022-2032)
- 7.4.3.6 Rest of Asia-Pacific Urology Ultrasound Devices Market Size in USD million (2022-2032)
- 7.4.4 Rest of the World (RoW)
- 7.4.4.1 Middle East Urology Ultrasound Devices Market Size in USD million (2022-2032)
- 7.4.4.2 Africa Urology Ultrasound Devices Market Size in USD million (2022-2032)
- 7.4.4.3 South America Urology Ultrasound Devices Market Size In USD Million (2022-2032)
- 8. Competitive Landscape
- 9. Startup Funding & Investment Trends
- 10. Urology Ultrasound Devices Market Company and Product Profiles
- 10.1 General Electric Company
- 10.1.1 Company Overview
- 10.1.2 Company Snapshot
- 10.1.3 Financial Overview
- 10.1.4 Product Listing
- 10.1.5 Entropy
- 10.2 ESAOTE SPA
- 10.2.1 Company Overview
- 10.2.2 Company Snapshot
- 10.2.3 Financial Overview
- 10.2.4 Product Listing
- 10.2.5 Entropy
- 10.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd
- 10.3.1 Company Overview
- 10.3.2 Company Snapshot
- 10.3.3 Financial Overview
- 10.3.4 Product Listing
- 10.3.5 Entropy
- 10.4 BK Medical Holding Company, Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Snapshot
- 10.4.3 Financial Overview
- 10.4.4 Product Listing
- 10.4.5 Entropy
- 10.5 Hitachi Medical Systems
- 10.5.1 Company Overview
- 10.5.2 Company Snapshot
- 10.5.3 Financial Overview
- 10.5.4 Product Listing
- 10.5.5 Entropy
- 10.6 Laborie
- 10.6.1 Company Overview
- 10.6.2 Company Snapshot
- 10.6.3 Financial Overview
- 10.6.4 Product Listing
- 10.6.5 Entropy
- 10.7 DRAMIŃSKI S.A.
- 10.7.1 Company Overview
- 10.7.2 Company Snapshot
- 10.7.3 Financial Overview
- 10.7.4 Product Listing
- 10.7.5 Entropy
- 10.8 Clarius Mobile Health Corp
- 10.8.1 Company Overview
- 10.8.2 Company Snapshot
- 10.8.3 Financial Overview
- 10.8.4 Product Listing
- 10.8.5 Entropy
- 10.9 AvantSonic Technology Co., Ltd
- 10.9.1 Company Overview
- 10.9.2 Company Snapshot
- 10.9.3 Financial Overview
- 10.9.4 Product Listing
- 10.9.5 Entropy
- 10.10 ProMed Solutions Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Snapshot
- 10.10.3 Financial Overview
- 10.10.4 Product Listing
- 10.10.5 Entropy
- 10.11 SIFSOF LLC
- 10.11.1 Company Overview
- 10.11.2 Company Snapshot
- 10.11.3 Financial Overview
- 10.11.4 Product Listing
- 10.11.5 Entropy
- 10.12 Shenzhen Ricso Technology Co., Ltd
- 10.12.1 Company Overview
- 10.12.2 Company Snapshot
- 10.12.3 Financial Overview
- 10.12.4 Product Listing
- 10.12.5 Entropy
- 10.13 Sonoscanner
- 10.13.1 Company Overview
- 10.13.2 Company Snapshot
- 10.13.3 Financial Overview
- 10.13.4 Product Listing
- 10.13.5 Entropy
- 10.14 Chengdu Healson Technology Co., Ltd
- 10.14.1 Company Overview
- 10.14.2 Company Snapshot
- 10.14.3 Financial Overview
- 10.14.4 Product Listing
- 10.14.5 Entropy
- 10.15 Healcerion Co., Ltd
- 10.15.1 Company Overview
- 10.15.2 Company Snapshot
- 10.15.3 Financial Overview
- 10.15.4 Product Listing
- 10.15.5 Entropy
- 10.16 Exact Imaging
- 10.16.1 Company Overview
- 10.16.2 Company Snapshot
- 10.16.3 Financial Overview
- 10.16.4 Product Listing
- 10.16.5 Entropy
- 10.17 ECHO-SON S.A.
- 10.17.1 Company Overview
- 10.17.2 Company Snapshot
- 10.17.3 Financial Overview
- 10.17.4 Product Listing
- 10.17.5 Entropy
- 10.18 Xindray Medical International Co., Ltd
- 10.18.1 Company Overview
- 10.18.2 Company Snapshot
- 10.18.3 Financial Overview
- 10.18.4 Product Listing
- 10.18.5 Entropy
- 10.19 KOELIS
- 10.19.1 Company Overview
- 10.19.2 Company Snapshot
- 10.19.3 Financial Overview
- 10.19.4 Product Listing
- 10.19.5 Entropy
- 10.20 Interson Corporation
- 10.20.1 Company Overview
- 10.20.2 Company Snapshot
- 10.20.3 Financial Overview
- 10.20.4 Product Listing
- 10.20.5 Entropy
- 11. KOL Views
- 12. Project Approach
- 13. About DelveInsight
- 14. Disclaimer & Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.